Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

We couldn't have done this without the generous support of Cancer Research UK." Because the drugs required for IC, carboplatin and paclitaxel, are cheap, accessible and already approved for use in ...

The proposed Medicare High-Value Drug List Model, also known as the Medicare $2 Drug List, could have modestly reduced out-of-pocket costs for 38% of beneficiaries if implemented in 2021.

In this article, we will be discussing the top 15 best-selling cancer drugs. If you are not interested in reading about the global cancer treatment market, head straight to the Top 5 Best Selling ...

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

$38,398 for a single shot of a very old cancer drug — and one "no-brainer" alternative By Arthur Allen October 26, 2022 / 5:00 AM EDT / Kaiser Health News ...

A shortage of cancer drugs is forcing doctors to confront the reality that some patients could die needlessly. “Lives will be shortened,” Dr. Patrick Timmins III, a gynecologic oncologist at ...

DRUG SHORTAGES IN CANCER, ASTHMA, TRANSPLANT, BACTERIAL INFECTION TREATMENTS. An NCCN survey of 27 U.S. cancer centers shows 93% have reported a shortage of Carboplatin, and 70% reported a ...

Hundreds of new priority anti-cancer drug targets, ... This will help drug developers focus their efforts on the highest value targets to bring new medicines to patients more quickly." ...

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills. That ...